Diabetic Foot and Venous Stasis Ulcers Clinical Trials

About Diabetic Foot and Venous Stasis Ulcers

Diabetic Foot Ulcer

A diabetic foot ulcer is an open sore, usually forming on the bottom of the foot. About 15% of people with diabetes develop these ulcers. They occur due to nerve damage, poor circulation, and pressure on the foot. Healing can take weeks or months, which increases the risk of infection and complications. Early care and proper management are essential to prevent worsening.

Venous Stasis Ulcer

A venous stasis ulcer is a long-lasting, shallow wound that usually appears on the lower leg or ankle. They occur when poor circulation (venous insufficiency) causes blood to pool, often leading to pain, itching, swelling, and discolored skin around the affected area.

Diabetic foot and venous stasis ulcers clinical trials are exploring potential new treatments to improve healing and reduce complications.

STUDY

Diabetic foot and venous stasis ulcers clinical trials are evaluating investigational treatments to support faster healing and better foot health. The purpose of this clinical trial is to compare standard of care therapy with different topical products that are already available. Throughout the study, patients are carefully monitored to ensure their safety and well-being. Regular checkups track the ulcer’s healing progress and overall foot health.

By taking part, patients may gain access to study treatments and contribute to research that could help others with diabetic foot and venous stasis ulcers. The study team documents results carefully to evaluate how effective and safe each therapy is. Joining a diabetic foot and venous stasis ulcers research study provides an opportunity to support medical research while exploring new treatment possibilities under close medical supervision.

Exploring Investigational Treatment for Diabetic Foot and Venous Stasis Ulcers

Age
21 years and older

Location:
Arizona

Status:
Active

Condition
Diabetic Foot and Venous Stasis Ulcers

What to Expect in a Clinical Trial

Following eligibility confirmation, participants attend scheduled study visits. During these visits, they may receive study-related treatment as outlined in the trial protocol. Participants are monitored by a well-trained research team throughout the trial. Regular assessments are conducted to track healing progress and identify any side effects early.

Medical professionals monitor safety at every stage of the study. Throughout the trial, the study team provides ongoing support and answers any questions or concerns that participants may have. This closely supervised approach helps ensure consistent care while contributing valuable insights to diabetic foot and venous stasis ulcer research.

Frequently Asked
Questions


  • Adults aged 21 years and older may be eligible. Participants must meet the study requirements to enroll in diabetic foot and venous stasis ulcers clinical trials.

  • Participants attend scheduled visits and follow the study plan. Their progress is tracked, and any changes in their condition are noted to help evaluate the treatment.

  • Adults aged 18 and older who have been diagnosed with hidradenitis suppurativa may qualify. Eligibility will be determined during a screening process that reviews specific health criteria.